Prof. Jens Huober (IMAGE)

European Society for Medical Oncology

Prof. Jens Huober

Caption

Prof. Jens Huober presenting the results of abstract 150O_PR "Pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression in patients with HER2-positive metastatic breast cancer (MBC)- The PERNETTA trial (SAKK 22/10), a randomized open label phase II study (SAKK, UNICANCER, BOOG)" by J. Huober et al

Credit

European Society for Medical Oncology

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.